Literature DB >> 25028513

β-III Tubulin fragments inhibit α-synuclein accumulation in models of multiple system atrophy.

Yasuyo Suzuki1, Chenghua Jin1, Tamaki Iwase2, Ikuru Yazawa3.   

Abstract

Multiple system atrophy (MSA) is a neurodegenerative disease caused by α-synuclein aggregation in oligodendrocytes and neurons. Using a transgenic mouse model overexpressing human α-synuclein in oligodendrocytes, we previously demonstrated that oligodendrocytic α-synuclein inclusions induce neuronal α-synuclein accumulation and progressive neuronal degeneration. α-Synuclein binds to β-III tubulin, leading to the neuronal accumulation of insoluble α-synuclein in an MSA mouse model. The present study demonstrates that α-synuclein co-localizes with β-III tubulin in the brain tissue from patients with MSA and MSA model transgenic mice as well as neurons cultured from these mice. Accumulation of insoluble α-synuclein in MSA mouse neurons was blocked by the peptide fragment β-III tubulin (residues 235-282). We have determined the α-synuclein-binding domain of β-III tubulin and demonstrated that a short fragment containing this domain can suppress α-synuclein accumulation in the primary cultured cells. Administration of a short α-synuclein-binding fragment of β-III tubulin may be a novel therapeutic strategy for MSA.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Multiple System Atrophy; Neurodegeneration; Protein Aggregation; Protein-Protein Interaction; Tubulin; alpha-Synuclein

Mesh:

Substances:

Year:  2014        PMID: 25028513      PMCID: PMC4148865          DOI: 10.1074/jbc.M114.557215

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  The intertransmembrane region of Kaposi's sarcoma-associated herpesvirus modulator of immune recognition 2 contributes to B7-2 downregulation.

Authors:  Mizuho Kajikawa; Pai-Chi Li; Eiji Goto; Naoyuki Miyashita; Masami Aoki-Kawasumi; Mari Mito-Yoshida; Mika Ikegaya; Yuji Sugita; Satoshi Ishido
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

2.  A pilot trial of the microtubule-interacting peptide (NAP) in mice overexpressing alpha-synuclein shows improvement in motor function and reduction of alpha-synuclein inclusions.

Authors:  Sheila M Fleming; Caitlin K Mulligan; Franziska Richter; Farzad Mortazavi; Vincent Lemesre; Carmen Frias; Chunni Zhu; Alistair Stewart; Illana Gozes; Bruce Morimoto; Marie-Françoise Chesselet
Journal:  Mol Cell Neurosci       Date:  2010-12-27       Impact factor: 4.314

3.  Proteolytic processing regulates pathological accumulation in dentatorubral-pallidoluysian atrophy.

Authors:  Yasuyo Suzuki; Kimiko Nakayama; Naohiro Hashimoto; Ikuru Yazawa
Journal:  FEBS J       Date:  2010-10-26       Impact factor: 5.542

Review 4.  Synthetic therapeutic peptides: science and market.

Authors:  Patrick Vlieghe; Vincent Lisowski; Jean Martinez; Michel Khrestchatisky
Journal:  Drug Discov Today       Date:  2009-10-30       Impact factor: 7.851

5.  α-Synuclein oligomers impair neuronal microtubule-kinesin interplay.

Authors:  Iryna Prots; Vanesa Veber; Stefanie Brey; Silvia Campioni; Katrin Buder; Roland Riek; Konrad J Böhm; Beate Winner
Journal:  J Biol Chem       Date:  2013-06-06       Impact factor: 5.157

6.  Binding of neuronal α-synuclein to β-III tubulin and accumulation in a model of multiple system atrophy.

Authors:  Kimiko Nakayama; Yasuyo Suzuki; Ikuru Yazawa
Journal:  Biochem Biophys Res Commun       Date:  2011-12-29       Impact factor: 3.575

7.  Impairment of microtubule-dependent trafficking by overexpression of alpha-synuclein.

Authors:  He-Jin Lee; Farnaz Khoshaghideh; Stephen Lee; Seung-Jae Lee
Journal:  Eur J Neurosci       Date:  2006-12       Impact factor: 3.386

8.  α-Synuclein accumulation reduces GABAergic inhibitory transmission in a model of multiple system atrophy.

Authors:  Hiroshi Ito; Kimiko Nakayama; Chenghua Jin; Yasuyo Suzuki; Ikuru Yazawa
Journal:  Biochem Biophys Res Commun       Date:  2012-10-23       Impact factor: 3.575

Review 9.  The many faces of α-synuclein: from structure and toxicity to therapeutic target.

Authors:  Hilal A Lashuel; Cassia R Overk; Abid Oueslati; Eliezer Masliah
Journal:  Nat Rev Neurosci       Date:  2013-01       Impact factor: 34.870

Review 10.  Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications.

Authors:  Daniel M Skovronsky; Virginia M-Y Lee; John Q Trojanowski
Journal:  Annu Rev Pathol       Date:  2006       Impact factor: 23.472

View more
  2 in total

1.  Autophagy-disrupted LC3 abundance leads to death of supporting cells of human oocytes.

Authors:  Woojin Kang; Eri Ishida; Kenji Yamatoya; Akihiro Nakamura; Mami Miyado; Yoshitaka Miyamoto; Maki Iwai; Kuniko Tatsumi; Takakazu Saito; Kazuki Saito; Natsuko Kawano; Toshio Hamatani; Akihiro Umezawa; Kenji Miyado; Hidekazu Saito
Journal:  Biochem Biophys Rep       Date:  2018-08-21

Review 2.  Insights into the pathogenesis of multiple system atrophy: focus on glial cytoplasmic inclusions.

Authors:  Seiji Kaji; Takakuni Maki; Tomoyuki Ishimoto; Hodaka Yamakado; Ryosuke Takahashi
Journal:  Transl Neurodegener       Date:  2020-02-17       Impact factor: 8.014

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.